﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/glenmark-pharmaceuticals-usa-to-launch-micafungin-for-injection-usp-50-mgvial-and-100-mgvial-17624</loc><lastmod>2025-08-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/alkem-launches-ceramide-boosting-moisturizing-lotion-for-skin-barrier-repair-17625</loc><lastmod>2025-08-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/alembic-receives-usfda-final-approval-for-macitentan-tablets-10-mg-17626</loc><lastmod>2025-08-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/novo-nordisks-wegovy-approved-in-the-us-for-the-treatment-of-mash-17627</loc><lastmod>2025-08-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/fda-approves-first-immunotherapy-for-recurrent-respiratory-papillomatosis-17628</loc><lastmod>2025-08-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/tonix-receives-fda-approval-of-tonmya-for-treatment-of-fibromyalgia-17629</loc><lastmod>2025-08-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/sarepta-advances-sirna-collaboration-and-sale-of-arrowhead-equity-investment-17630</loc><lastmod>2025-08-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/bioage-labs-doses-first-patient-in-bge-102-phase-1-trial-17631</loc><lastmod>2025-08-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/pfizers-sickle-cell-disease-candidate-fails-phase-iii-trial-17632</loc><lastmod>2025-08-19T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>